Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation

International Immunopharmacology

Volumn 2, Issue 13-14, 2002, Pages 1861-1865

  Gozzo, Andrezza J ^a   Nunes, Viviane A ^a   Carmona, Adriana K ^a   Nader, Helena B ^a   Von Dietrich, Carl Peter ^a   Silveira, Vera L F ^b   Shimamoto, Kazuaki ^c   Ura, Nobuyuki ^c   Sampaio, Misako U ^a   Sampaio, Claudio A M ^a   Araújo, Mariana S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b EPM   (Brazil)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bradykinin; Glycosaminoglycans; High molecular weight kininogen; Human plasma kallikrein; Paw edema

Indexed keywords

BRADYKININ; CARRAGEENAN; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; KININOGEN; PLASMA KALLIKREIN; AUTACOID; HIGH MOLECULAR WEIGHT KININOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; EDEMA; INFLAMMATION; MALE; MATHEMATICAL COMPUTING; NONHUMAN; PAW EDEMA; PLASMA; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; HUMAN; HYDROLYSIS; KINETICS; METABOLISM; WISTAR RAT;

ANIMALS; BRADYKININ; CARRAGEENAN; DERMATAN SULFATE; EDEMA; HUMANS; HYDROLYSIS; INFLAMMATION; INFLAMMATION MEDIATORS; KINETICS; KININOGEN, HIGH-MOLECULAR-WEIGHT; MALE; PLASMA KALLIKREIN; RATS; RATS, WISTAR;

EID: 0036891752     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00145-5     Document Type: Article

References (25)

1. Rocha e Silva M., Beraldo W.T., Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am. J. Physiol. 150:1949;261.
2. Kaplan A.P., Joseph K., Silverberg M. Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 109(2):2002;195-209.
3. Colman R.W., Schmaier A.H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood. 90(10):1997;3819-3843.
4. McMullen B.A., Fujikawa K., Davie E.W. Location of the disulfide bonds in human plasma prekallikrein: the presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry. 30:1991;2050-2056.
5. Mandle R.J., Colman R.W., Kaplan A.P. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc. Natl. Acad. Sci. U. S. A. 73(11):1976;4179-4183.
6. Weisel J.W., Nagaswami C., Woodhead J.L., DeLa Cadena R.A., Page J.D., Colman R.W. The shape of high molecular weight kininogen: organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. J. Biol. Chem. 269:1994;10100-10106.
7. Olson S.T., Sheffer R., Francis A.M. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein. Biochemistry. 32(45):1993;12136-12147.
8. Lin Y., Pixley R.A., Colman R.W. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin. Biochemistry. 39(17):2000;5104-5110.
9. Wuillemin W.A., Eldering E., Citarella F., de Ruig C.P., ten Cate H., Hack C.E. Modulation of contact system proteinases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa. J. Biol. Chem. 271(22):1996;12913-12918.
10. Brunnee T., Reddigari S.R., Shibayama Y., Kaplan A.P., Silverberg M. Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions. Clin. Exp. Allergy. 27(6):1997;653-663.
11. Mauron T., Lammle B., Wuillemin W.A. Related influence of low molecular weight heparin and low molecular weight dextran sulfate on the inhibition of coagulation factor XIa by serpins. Thromb. Haemost. 80(1):1998;82-86.
12. Nader H.B., Ferreira T.M., Paiva J.F., Medeiros M.G., Jeronimo S.M., Paiva V.M.et al. Isolation and structural studies of heparan sulfates and chondroitin sulfates from three species of molluscs. J. Biol. Chem. 259(3):1984;1431-1435.
13. Nader H.B., Kobayashi E.Y., Chavante S.F., Tersariol I.L., Castro R.A., Shinjo S.K.et al. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin. Glycoconj. J. 16(6):1999;265-270.
14. Shimamoto K., Ando T., Tanaka S., Nakahashi Y., Nishitani T., Hosoda S.et al. An improved method for the determination of human blood kinin levels by sensitive kinin radioimmunoassay. Endocrinol. Jpn. 29(4):1982;487-494.
15. Sampaio C., Wong S.C., Shaw E. Human plasma kallikrein. Purification and preliminary characterization. Arch. Biochem. Biophys. 165(1):1974;133-139.
16. Oliva M.L., Sampaio U.M., Sampaio C.A. Serine- and SH-proteinase inhibitors from Enterolobium contortisiliquum beans. Purification and preliminary characterization. Braz. J. Med. Biol. Res. 20(6):1987;767-770.
17. Morrison J.F. The slow-binding and slow-tight-binding inhibition of enzyme-catalyzed reactions. TIBS. 1982;102-105.
18. Araújo M.S., Andreotti R., Tiaen M.A., Nunes V., Oliva M.L.V.et al. Caiman crocodilus yacare plasma kininogen detection. Immunopharmacology. 32:1996;82-84.
19. Wilkinson G.N. Statistical estimations in enzyme kinetics. Biochem. J. 80:1961;324-332.
20. van der Graaf F., Tans G., Bouma B.N., Griffin J.H. Isolation and functional properties of the heavy and light chains of human plasma kallikrein. J. Biol. Chem. 257(23):1982;14300-14305.
21. Tayeh M.A., Olson S.T., Shore J.D. Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein. J. Biol. Chem. 269(23):1994;16318-16325.
22. Zhao M., Abdel-Razek T., Sun M.F., Gailani D. Characterization of heparin binding site on the heavy chain of factor XI. J. Biol. Chem. 273(47):1998;31153-31159.
23. Lin Y., Pixley R.A., Colman R.W. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin. Biochemistry. 39(17):2000;5104-5110.
24. Damas J., Bourdon V., Remacle-Volon G., Adam A. Kinins and peritoneal exudates induced by carrageenin and zymosan in rats. Br. J. Pharmacol. 101(2):1990;418-422.
25. Asano M., Hatori C., Inamura N., Sawai H., Hirosumi J., Fujiwara T.et al. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation. Br. J. Pharmacol. 122(7):1997;1436-1440.